Literature DB >> 12852458

Optimization of dissolution test precision for a ketoprofen oral extended-release product.

S Furlanetto1, F Maestrelli, S Orlandini, S Pinzauti, P Mura.   

Abstract

An example of application of experimental design methodologies to the set up of dissolution test conditions for a new ketoprofen oral extended-release dosage form is presented. The aim of the work was to find the best experimental conditions, using a USP apparatus 2 (paddle), for maximizing the method precision as degree of repeatability. The considered factors mainly influencing the dissolution test results were pH and volume of dissolution medium, and paddle stirring speed. Two distinct 4-run Plackett-Burman designs were carried out: one at gastric and the other at intestinal pH values. Each run was performed in triplicate in order to calculate the standard deviations of the drug dissolution efficiency at 60 and 120 min, selected as responses to be minimized. Optimum conditions to carry out the dissolution test were: 900 ml volume of dissolution medium and 70 rpm paddle stirring speed for both environments and pH 1 and 5.5, for the gastric and intestinal environment, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12852458     DOI: 10.1016/s0731-7085(03)00032-3

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Experimental design for the formulation and optimization of novel cross-linked oilispheres developed for in vitro site-specific release of Mentha piperita oil.

Authors:  Wilbert Sibanda; Viness Pillay; Michael P Danckwerts; Alvaro M Viljoen; Sandy van Vuuren; Riaz A Khan
Journal:  AAPS PharmSciTech       Date:  2004-03-12       Impact factor: 3.246

Review 2.  The science of USP 1 and 2 dissolution: present challenges and future relevance.

Authors:  Vivian Gray; Gregg Kelly; Min Xia; Chris Butler; Saji Thomas; Stephen Mayock
Journal:  Pharm Res       Date:  2009-01-23       Impact factor: 4.200

3.  Beta-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies.

Authors:  M Narender Reddy; Tasneem Rehana; S Ramakrishna; K P R Chowdhary; P V Diwan
Journal:  AAPS PharmSci       Date:  2004-03-05

4.  Development and Validation of In Vitro Discriminatory Dissolution Testing Method for Fast Dispersible Tablets of BCS Class II Drug.

Authors:  Shailendra Bhatt; Dabashis Roy; Manish Kumar; Renu Saharan; Anuj Malik; Vipin Saini
Journal:  Turk J Pharm Sci       Date:  2020-02-19

5.  Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules.

Authors:  Yinhe Tan; Xiaoqing Si; Lulu Zhong; Xin Feng; Xinmin Yang; Min Huang; Chuanbin Wu
Journal:  Drug Dev Ind Pharm       Date:  2016-04-11       Impact factor: 3.225

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.